Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...
FCB India, part of the IPG Group, has been awarded the creative mandate for Dulcoflex, a renowned brand in digestive health.
Sanofi Consumer Healthcare India Limited ( ($IN:SANOFICONR) ) just unveiled an update. Sanofi Consumer Healthcare India ...
Sanofi Consumer Healthcare India Limited has informed the Exchange that the Record date for the purpose of Dividend is 28th April 2025 ...
GlobalData on MSN12d
Sanofi moves closer to selling controlling stake in $17bn-valued OpellaSanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.
Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton ...
The pharma signed an agreement handing PE firm CD&R a 50% stake in its Capella unit. Elsewhere, Gilead and Ultragenyx secured ...
The company faced headwinds in the December 2024 quarter (Q4) as it reported a significant decline in earnings.
Sanofi Consumer Healthcare declares ₹55 final dividend even as Q4 profit drops 35%, margins shrink
The company announced its Q4 results after-market hours. Its shares ended 0.4% higher on Thursday at ₹4,759.35 on the BSE.
Kuehne+Nagel supports Sanofi in multiple countries worldwide, including Hungary, the UK, and the UAE, by providing customised ...
Sanofi Consumer Healthcare India Q4 Results 2025 on 21 Feb, 2025: Revenue decreased by 20.53% YoY & profit decreased by 34.66% YoY, profit at ₹44.3 crore and revenue at ₹170.7 crore.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback